Advertisement

AAPS PharmSciTech

, Volume 19, Issue 8, pp 3355–3361 | Cite as

Influence of Geometry on the Drug Release Profiles of Stereolithographic (SLA) 3D-Printed Tablets

  • Pamela Robles Martinez
  • Alvaro Goyanes
  • Abdul W. Basit
  • Simon Gaisford
Research Article Theme: Printing and Additive Manufacturing
Part of the following topical collections:
  1. Theme: Printing and Additive Manufacturing

Abstract

Additive manufacturing (3D printing) permits the fabrication of tablets in shapes unattainable by powder compaction, and so the effects of geometry on drug release behavior is easily assessed. Here, tablets (printlets) comprising of paracetamol dispersed in polyethylene glycol were printed using stereolithographic 3D printing. A number of geometric shapes were produced (cube, disc, pyramid, sphere and torus) with either constant surface area (SA) or constant surface area/volume ratio (SA/V). Dissolution testing showed that printlets with constant SA/V ratio released drug at the same rate, while those with constant SA released drug at different rates. A series of tori with increasing SA/V ratio (from 0.5 to 2.4) were printed, and it was found that dissolution rate increased as the SA/V ratio increased. The data show that printlets can be fabricated in multiple shapes and that dissolution performance can be maintained if the SA/V ratio is constant or that dissolution performance of printlets can be fine-tuned by varying SA/V ratio. The results suggest that 3D printing is therefore a suitable manufacturing method for personalized dosage forms.

KEY WORDS

three-dimensional printing additive manufacturing acetaminophen tablets stereolithography 

References

  1. 1.
    Trenfield SJ, Awad A, Goyanes A, Gaisford S, Basit AW. 3D printing pharmaceuticals: drug development to frontline care. Trends Pharmacol Sci. 2018;39:440–51.  https://doi.org/10.1016/J.TIPS.2018.02.006.CrossRefGoogle Scholar
  2. 2.
    Gökçe EH, Özyazici M, Ertan G. The effect of geometric shape on the release properties of metronidazole from lipid matrix tablets. J Biomed Nanotechnol. 2009;5:421–7.  https://doi.org/10.1166/jbn.2009.1052.CrossRefGoogle Scholar
  3. 3.
    Karasulu HY, Ertan G. Different geometric shaped hydrogel theophylline tablets: statistical approach for estimating drug release. Farmaco. 2002;57:939–45.CrossRefGoogle Scholar
  4. 4.
    Skoug JW, Borin MT, Fleishaker JC, Cooper AM. In vitro and in vivo evaluation of whole and half tablets of sustained-release Adinazolam Mesylate. Pharm Res. 1991;8:1482–8.  https://doi.org/10.1023/A:1015834114359.CrossRefGoogle Scholar
  5. 5.
    Karasulu HY, Ertan G, Köse T. Modeling of theophylline release from different geometrical erodible tablets. Eur J Pharm Biopharm. 2000;49:177–82.CrossRefGoogle Scholar
  6. 6.
    Raju PN, Prakash K, Rao TR, Reddy BCS, Sreenivasulu V, Narasu ML. Effect of tablet surface area and surface area/volume on drug release from lamivudine extended release matrix tablets. Int J Pharm Sci Nanotech. 2010;3:872–6.Google Scholar
  7. 7.
    Awad A, Trenfield SJ, Goyanes A, Gaisford S, Basit AW. Reshaping drug development using 3D printing. Drug Discov Today. 2018.  https://doi.org/10.1016/j.drudis.2018.05.025.CrossRefGoogle Scholar
  8. 8.
    Fina F, Goyanes A, Gaisford S, Basit AW. Selective laser sintering (SLS) 3D printing of medicines. Int J Pharm. 2017;529:285–93.  https://doi.org/10.1016/J.IJPHARM.2017.06.082.CrossRefGoogle Scholar
  9. 9.
    Goyanes A, Scarpa M, Kamlow M, Gaisford S, Basit AW, Orlu M. Patient acceptability of 3D printed medicines. Int J Pharm. 2017;530:71–8.  https://doi.org/10.1016/j.ijpharm.2017.07.064.CrossRefGoogle Scholar
  10. 10.
    Goyanes A, Martinez PR, Buanz A, Basit A, Gaisford S. Effect of geometry on drug release from 3D printed tablets. Int J Pharm. 2015;494:657–63.  https://doi.org/10.1016/j.ijpharm.2015.04.069.CrossRefGoogle Scholar
  11. 11.
    Fouassier JP, Lalevée J. Photopolymerization and photo-cross-linking. In: Photoinitiators for polymer synthesis. Weinheim: Wiley-VCH Verlag GmbH & Co. KGaA; 2012. p. 3–9.  https://doi.org/10.1002/9783527648245.ch1.CrossRefGoogle Scholar
  12. 12.
    Liu F, Merchant HA, Kulkarni RP, Alkademi M, Basit AW. Evolution of a physiological pH 6.8 bicarbonate buffer system: application to the dissolution testing of enteric coated products. Eur J Pharm Biopharm. 2011;78:151–7.  https://doi.org/10.1016/j.ejpb.2011.01.001.CrossRefGoogle Scholar
  13. 13.
    Fadda HM, Merchant HA, Arafat BT, Basit AW. Physiological bicarbonate buffers: stabilisation and use as dissolution media for modified release systems. Int J Pharm. 2009;382:56–60.  https://doi.org/10.1016/j.ijpharm.2009.08.003.CrossRefGoogle Scholar
  14. 14.
    Varum F, Merchant HA, Goyanes A, Assi P, Zboranová V, Basit AW. Accelerating the dissolution of enteric coatings in the upper small intestine: Evolution of a novel pH 5.6 bicarbonate buffer system to assess drug release. Int J Pharm. 2018;468(1–2):172–7.  https://doi.org/10.1016/j.ijpharm.2014.04.019.CrossRefGoogle Scholar
  15. 15.
    Goyanes A, Hatton GB, Merchant HA, Basit AW. Gastrointestinal release behaviour of modified-release drug products: dynamic dissolution testing of mesalazine formulations. Int J Pharm. 2015;484:103–8.  https://doi.org/10.1016/j.ijpharm.2015.02.051.CrossRefGoogle Scholar
  16. 16.
    Wang J, Goyanes A, Gaisford S, Basit AW. Stereolithographic (SLA) 3D printing of oral modified-release dosage forms. Int J Pharm. 2016;503:207–12.  https://doi.org/10.1016/j.ijpharm.2016.03.016.CrossRefGoogle Scholar
  17. 17.
    Martinez PR, Goyanes A, Basit AW, Gaisford S. Fabrication of drug-loaded hydrogels with stereolithographic 3D printing. Int J Pharm. 2017;532:313–7.  https://doi.org/10.1016/j.ijpharm.2017.09.003.CrossRefGoogle Scholar
  18. 18.
    Goyanes A, Buanz ABM, Hatton GB, Gaisford S, Basit AW. 3D printing of modified-release aminosalicylate (4-ASA and 5-ASA) tablets. Eur J Pharm Biopharm. 2014;89:157–62.  https://doi.org/10.1016/j.ejpb.2014.12.003.CrossRefGoogle Scholar
  19. 19.
    Parojcić J, Durić Z, Jovanović M, Ibrić S. An investigation into the factors influencing drug release from hydrophilic matrix tablets based on novel carbomer polymers. Drug Deliv. 2004;11:59–65.  https://doi.org/10.1080/10717540490265379.CrossRefGoogle Scholar
  20. 20.
    Reynolds TD, Mitchell S, Balwinski KM. Investigation of the effect of tablet surface area/volume on drug release from hydroxypropylmethylcellulose controlled-release matrix tablets. Drug Dev Ind Pharm. 2002;28:457–66.  https://doi.org/10.1081/DDC-120003007.CrossRefGoogle Scholar
  21. 21.
    Kim C. Compressed donut-shaped tablets with zero-order release kinetics. Pharm Res. 1995;12:1045–8.  https://doi.org/10.1023/A:1016218716951.CrossRefGoogle Scholar
  22. 22.
    Kim C. Release kinetics of coated, donut-shaped tablets for water soluble drugs. Eur J Pharm Sci. 1999;7:237–42.CrossRefGoogle Scholar
  23. 23.
    Fina F, Madla CM, Goyanes A, Zhang J, Gaisford S, Basit AW. Fabricating 3D printed orally disintegrating printlets using selective laser sintering. Int J Pharm. 2018; 541(1–2):101–7.  https://doi.org/10.1016/j.ijpharm.2018.02.015.CrossRefGoogle Scholar
  24. 24.
    Fina F, Goyanes A, Madla CM, Awad A, Trenfield SJ, Min Kuek J, et al. 3D printing of drug-loaded gyroid lattices using selective laser sintering. Int J Pharm. 2018;547(1–2):44–52.  https://doi.org/10.1016/j.ijpharm.2018.05.044.CrossRefGoogle Scholar

Copyright information

© American Association of Pharmaceutical Scientists 2018

Authors and Affiliations

  • Pamela Robles Martinez
    • 1
  • Alvaro Goyanes
    • 1
  • Abdul W. Basit
    • 1
  • Simon Gaisford
    • 1
  1. 1.UCL School of PharmacyUniversity College LondonLondonUK

Personalised recommendations